2005
Incentive Program Decreases No-Shows in Nontreatment Substance Abuse Research
Pollastri AR, Pokrywa ML, Walsh SJ, Kranzler HR, Gelernter J. Incentive Program Decreases No-Shows in Nontreatment Substance Abuse Research. Experimental And Clinical Psychopharmacology 2005, 13: 376-380. PMID: 16366768, DOI: 10.1037/1064-1297.13.4.376.Peer-Reviewed Original Research
1990
Neuropeptide Y-like immunoreactivity in schizophrenia Relationships with clinical measures
Peters J, Van Kammen D, Gelernter J, Yao J, Shaw D. Neuropeptide Y-like immunoreactivity in schizophrenia Relationships with clinical measures. Schizophrenia Research 1990, 3: 287-294. PMID: 2178001, DOI: 10.1016/0920-9964(90)90012-v.Peer-Reviewed Original ResearchConceptsCSF NPY-liNPY-LINeuropeptide YLike immunoreactivityDrug-free chronic schizophrenic patientsDrug-free patientsChronic schizophrenic patientsStructural brain abnormalitiesDrug-free controlsAspects of schizophreniaHaloperidol withdrawalPatient's CSFHaloperidol treatmentMaintenance treatmentBrain abnormalitiesClinical measuresCT scanSchizophrenic patientsPositive symptomsPatientsLonger durationSignificant differencesSignificant increasePresent findingsImmunoreactivity